The design and synthesis of thrombin inhibitors: Analogues of MD805 containing non-polar surrogates for arginine at the P1 position

被引:10
|
作者
Baettig, U [1 ]
Brown, L [1 ]
Brundish, D [1 ]
Dell, C [1 ]
Furzer, A [1 ]
Garman, S [1 ]
Janus, D [1 ]
Kane, PD [1 ]
Smith, G [1 ]
Walker, CV [1 ]
Cockcroft, XL [1 ]
Ambler, J [1 ]
Mitchelson, A [1 ]
Talbot, MD [1 ]
Tweed, M [1 ]
Wills, N [1 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 4AB, W Sussex, England
关键词
D O I
10.1016/S0960-894X(00)00282-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of monocyclic and bicyclic amino acids have been synthesised and incorporated into thrombin inhibitors based on CGH728, an analogue of the Mitsubishi compound MD805. Benzthiazolylalanine (Bta) was found to be a good non-polar substitute for arginine at the P1 position, yielding compounds with low nanomolar potency and good selectivity for thrombin. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1563 / 1566
页数:4
相关论文
共 25 条
  • [1] Design and synthesis of thrombin inhibitors: Analogues of MD-805 with reduced stereogenicity and improved potency
    Brundish, D
    Bull, A
    Donovan, V
    Fullerton, JD
    Garman, SM
    Hayler, JF
    Janus, D
    Kane, PD
    McDonnell, M
    Smith, GP
    Wakeford, R
    Walker, CV
    Howarth, G
    Hoyle, W
    Allen, MC
    Ambler, J
    Butler, K
    Talbot, MD
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) : 4584 - 4603
  • [2] Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position
    Tucker, TJ
    Brady, SF
    Lumma, WC
    Lewis, SD
    Gardell, SJ
    Naylor-Olsen, AM
    Yan, YW
    Sisko, JT
    Stauffer, KJ
    Lucas, BJ
    Lynch, JJ
    Cook, JJ
    Stranieri, MT
    Holahan, MA
    Lyle, EA
    Baskin, EP
    Chen, IW
    Dancheck, KB
    Krueger, JA
    Cooper, CM
    Vacca, JP
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) : 3210 - 3219
  • [3] The design and synthesis of a series of potent and orally bioavailable non-covalent thrombin inhibitors that utilize non-basic groups in the P1 position.
    Tucker, TJ
    Brady, SF
    Lumma, WC
    Lewis, SD
    Gardell, SJ
    Naylor-Olsen, AM
    Yan, YW
    Sisko, JT
    Stauffer, KJ
    Lucas, BJ
    Lynch, JJ
    Cook, JJ
    Stranieri, MT
    Holahan, MA
    Lyle, EA
    Baskin, EP
    Chen, IW
    Dancheck, KB
    Krueger, JA
    Cooper, CM
    Vacca, JP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U207 - U207
  • [4] Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-bicyclic arginine surrogates
    Cui, JRJ
    Araldi, GL
    Reiner, JE
    Reddy, KM
    Kemp, SJ
    Ho, JZ
    Siev, DV
    Mamedova, L
    Gibson, TS
    Gaudette, JA
    Minami, NK
    Anderson, SM
    Bradbury, AE
    Nolan, TG
    Semple, JE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (20) : 2925 - 2930
  • [5] Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-monocyclic arginine surrogates
    Reiner, JE
    Siev, DV
    Araldi, GL
    Cui, JRJ
    Ho, JZ
    Reddy, KM
    Mamedova, L
    Vu, PH
    Lee, KSS
    Minami, NK
    Gibson, TS
    Anderson, SM
    Bradbury, AE
    Nolan, TG
    Semple, JE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (08) : 1203 - 1208
  • [6] Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-monocyclic arginine surrogates.
    Semple, JE
    Reiner, JE
    Cui, JRJ
    Siev, DV
    Araldi, GL
    Ho, JZ
    Vu, PH
    Lee, KSS
    Minami, NK
    Gibson, TS
    Givson, TS
    Anderson, SM
    Bradbury, AE
    Nolan, TG
    Dixon, SA
    Ma, MG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U679 - U679
  • [7] Potent non-covalent thrombin inhibitors featuring P3-heterocycles with P1-aminobenzisoxazole arginine surrogates.
    Semple, JE
    Araldi, GL
    Cui, JRJ
    Kemp, S
    Komandla, M
    Siev, DV
    Mamedova, L
    Reiner, JE
    Gibson, TS
    Gaudette, JA
    Minami, N
    Lawrence, CM
    Anderson, SM
    Bradbury, AE
    Nolan, TG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U57 - U57
  • [8] Novel non-covalent azaphenylalanine thrombin inhibitors with an amino-methyl or amino group at the P1 position
    Obreza, A
    Stegnar, M
    Urleb, U
    PHARMAZIE, 2004, 59 (09): : 659 - 667
  • [9] Design, synthesis, and biological evaluation of pyrazinones containing novel P1 needles as inhibitors of TF/VIIa
    Trujillo, John I.
    Huang, Horng-Chih
    Neumann, William L.
    Mahoney, Matthew W.
    Long, Scott
    Huang, Wei
    Garland, Danny J.
    Kusturin, Carrie
    Abbas, Zaheer
    South, Michael S.
    Reitz, David B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4568 - 4574
  • [10] Novel inhibitors of HIV protease: Design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds
    Spaltenstein, A
    Almond, MR
    Bock, WJ
    Cleary, DG
    Furfine, ES
    Hazen, RJ
    Kazmierski, WM
    Salituro, FG
    Tung, RD
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) : 1159 - 1162